Diamant Thaçi is Director and Full Professor at the Institute and Comprehensive Center for Inflammation Medicine at the University of Lübeck in Lübeck, Germany, positions he has held since 2013. He is also Chair of the Inflammatory Board at the Lübeck campus of the University Hospital Schleswig-Holstein.
Professor Thaçi graduated in 1989 with a medical degree, and in 1995, he specialized in dermatology and venereology at the Department of Dermatology and Venereology of the Johann Wolfgang Goethe University in Frankfurt am Main, Germany. Here he held the roles of Senior Consulting Specialist in Dermatology, Director of Clinical Research, and Head of the Photodermatology Division between 1997 and 2011. In 2011, he was appointed Associate Professor of Dermatology, Venereology, and Allergology at the Goethe University in Frankfurt am Main, Germany.
Professor Thaçi’s research experience covers immunological work in basic research as well as all stages of clinical drug development, especially in chronic inflammatory skin diseases, including psoriasis, atopic dermatitis, and hidradenitis suppurativa.
Professor Thaçi has been a recipient of the Theodor-Stern Foundation Award for excellence in clinical research. He has been involved in numerous investigator-driven trials and has acted as Principal Investigator on a large number of national and international multicentre trials. In addition to his clinical commitments, Professor Thaçi also lectures on dermatology and cross-section immunology/microbiology, and has published numerous articles in highly regarded journals, including The New England Journal of Medicine and The Lancet. He has been an Editor, Co-Editor, and Editorial Board member for several scientific journals, and serves as a scientific reviewer of not only dermatological but also general medical journals. He is an active member of the Steering Committee of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), the International Psoriasis Council (IPC), the International Eczema Council (IEC), and the Skin Inflammation and Psoriasis International Network (SPIN).
CP-334476 - Date of preparation: July 2022